Company
Proteome Sciences PLC
LON:PRM
Proteome Sciences plc is a Leader in Applied Proteomics and Peptidomics We deliver content for Precision Medicine through services, biomarkers and reagents. We use high sensitivity proprietary technologies to detect biomarkers across major human diseases in areas of significant unmet need where biomarkers have the potential to transform disease management and treatment for the first time at the level of the individual. Our proteomics expertise provides complementary and enabling content and insight for our strategic partners to develop more effective, time and cost-efficient healthcare solutions.
35 stories
Archive
Braveheart heads for stellar close after update on investee’s COVID-19 test
A look at Friday's major share movers on the London Stock Exchange
Archive
FTSE 100 closes in the red
The FTSE 100 closed at 5,791 on Tuesday, a 51-point loss on the day to finish 0.9% below its opening levels
Archive
FTSE 100 closes in red as China manufacturing data sends chill
The UK's premier share index shed over 22 points at 7,418, while the FTSE 250 shed over 86 points at 19,824
Archive
Impressive first quarter performance needed from oil giant BP after recent share price rally
The Day Ahead also brings updates from the likes of blue-chip lender Standard Chartered, Premier Inn owner Whitbread and pubs group Greene King
Archive
FTSE 100 closes up as rally continues but US shares lag
A bad day for sterling but a good day for blue-chip equities
Archive
Brexit impasse could still bring a UK general election which could boost polling firm YouGov
Aside from YouGov's results, the Day Ahead will also bring results from fellow small caps Next Fifteen Communications and Hostelworld, plus a key EGM for fashion firm Superdry
Archive
US jobs to provide main focus, though UK PMIs still key as Brexit SNAFU continues
Aside from the UK and US data - and Brexit - corporate news in the week ahead will include updates from blue-chip budget airline easyjet and Ladbrokes Coral owner GVC Holdings
FTSE 100 closes firmly higher with miners taking the top spots
The global financial body added that several countries, including the US and UK, had excessive current account deficits and borrowed too much
Archive
Investors looking for some thirst quenchers from Britvic, Fevertree, and Fuller's
Aside from the soft drinks firms and brewer, the day ahead on Tuesday includes updates from blue-chip real estate firm Hammerson and student acommodation group Unite
FTSE 100 extends gains in the final sessions
Stocks consolidated gains at the death with bid stock Shire the best performing blue-chip
Archive
Market volatility expected to give boost to London Stock Exchange revenues
Day ahead includes latest trading updates from bourses operator London Stock Exchange and blue chip wealth manager St James' Place
Archive
Small cap movers: Electric vehicles boost for Pan African Minerals and Cadence
A look back at some of this week's more interesting stories from the junior market
RTC Group booms as it inks long-term contract with energy giant SSE
A glance at some of the bigger risers and fallers in London this afternoon...
Archive
PZ Cussons among few features on a summery Tuesday
The agenda for Tuesday is distinctly summery, albeit PZ Cussons is among a few features in the books.
Archive
Horse Hill stakeholder Primorus Investments PLC joins the recovery stocks virtual portfolio
The portfolio could do with a bit of hysteria over the Gatwick Gusher to perk up its performance
Archive
Bombed Out but Bouncing Back portfolio rises 46% in 11 days
It's all down to the astonishing rise of mySquar (with a nod of acknowledgement to Bilby, too)
Sirius and Sound burnish credentials with news market has been waiting for
Sirius Minerals concluded a fundraising, while Sound made a significant gas find
Risers and fallers: Amur Minerals, Jersey Oil and Gas, Motif Bio
Shares in explorer Amur Minerals soared on Monday after it announced a tie with Chinese nickel giant Jinchuan
Risers and fallers: TyraTech, Crawshaw and JRP …
TyraTech's share price rose this afternoon after one of its non-executive directors bought half a million shares at a 25% premium
Proteome Sciences narrows losses after sales rose in 2015
The rise of 'precision medicine' continues to support the biomarker business with revenues from licensing, sales and services up 30% in 2015.
Investments and investor services
Risers & Fallers: EMED, Clontarf, Proteome, Gable, LGO, Central Rand Gold and more.
Proteome gave a bullish update on its pipeline situation while Central Rand Gold struggles to sell its Dutch arm.
Investments and investor services
Risers and Fallers including Motive TV, Concha, Phorm, Proteome Sciences, Hargreaves Services...
Phorm was a big loser again today while Motive TV has added a record feature to its over-the-top television app sending shares higher.